Financhill
Buy
70

HIMS Quote, Financials, Valuation and Earnings

Last price:
$55.49
Seasonality move :
-1.99%
Day range:
$54.67 - $57.68
52-week range:
$13.47 - $72.98
Dividend yield:
0%
P/E ratio:
80.41x
P/S ratio:
7.50x
P/B ratio:
22.61x
Volume:
26.4M
Avg. volume:
51.1M
1-year change:
127.66%
Market cap:
$12.4B
Revenue:
$1.5B
EPS (TTM):
$0.69

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
HIMS
Hims & Hers Health
$538.9M $0.23 73.98% 273.73% $49.80
EWCZ
European Wax Center
$49.7M $0.05 -4.6% 75.92% $6.71
GROV
Grove Collaborative Holdings
$47M -$0.03 -14.72% -67.86% $2.10
KVUE
Kenvue
$3.7B $0.23 -1.27% 835.9% $24.54
SKIN
The Beauty Health
$63.1M -$0.07 -18.24% -80% $1.76
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
HIMS
Hims & Hers Health
$55.48 $49.80 $12.4B 80.41x $0.00 0% 7.50x
EWCZ
European Wax Center
$5.74 $6.71 $248.8M 28.14x $0.00 0% 1.21x
GROV
Grove Collaborative Holdings
$1.15 $2.10 $46.3M -- $0.00 0% 0.22x
KVUE
Kenvue
$21.45 $24.54 $41.2B 39.00x $0.21 3.82% 2.70x
SKIN
The Beauty Health
$1.53 $1.76 $192.8M -- $0.00 0% 0.63x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
HIMS
Hims & Hers Health
-- 7.831 -- 1.18x
EWCZ
European Wax Center
84.28% 3.372 189.52% 1.88x
GROV
Grove Collaborative Holdings
36.37% 3.246 9.48% 0.37x
KVUE
Kenvue
46.19% 0.455 18.75% 0.58x
SKIN
The Beauty Health
92.31% 2.498 329.49% 6.31x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
HIMS
Hims & Hers Health
$430.7M $57.9M 37.84% 37.84% 9.88% $50.1M
EWCZ
European Wax Center
$38.2M $10.6M 1.97% 9.03% 20.58% $12M
GROV
Grove Collaborative Holdings
$23.1M -$3.5M -49.78% -164.34% -7.33% -$7.4M
KVUE
Kenvue
$2.2B $618M 5.62% 10.32% 15.1% $249M
SKIN
The Beauty Health
$48.6M -$12M -6.09% -66.39% -9.64% $1.9M

Hims & Hers Health vs. Competitors

  • Which has Higher Returns HIMS or EWCZ?

    European Wax Center has a net margin of 8.44% compared to Hims & Hers Health's net margin of 3.37%. Hims & Hers Health's return on equity of 37.84% beat European Wax Center's return on equity of 9.03%.

    Company Gross Margin Earnings Per Share Invested Capital
    HIMS
    Hims & Hers Health
    73.5% $0.20 $549.3M
    EWCZ
    European Wax Center
    74.19% $0.04 $476.1M
  • What do Analysts Say About HIMS or EWCZ?

    Hims & Hers Health has a consensus price target of $49.80, signalling downside risk potential of -10.25%. On the other hand European Wax Center has an analysts' consensus of $6.71 which suggests that it could grow by 16.97%. Given that European Wax Center has higher upside potential than Hims & Hers Health, analysts believe European Wax Center is more attractive than Hims & Hers Health.

    Company Buy Ratings Hold Ratings Sell Ratings
    HIMS
    Hims & Hers Health
    4 6 1
    EWCZ
    European Wax Center
    3 4 1
  • Is HIMS or EWCZ More Risky?

    Hims & Hers Health has a beta of 2.094, which suggesting that the stock is 109.43% more volatile than S&P 500. In comparison European Wax Center has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock HIMS or EWCZ?

    Hims & Hers Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. European Wax Center offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Hims & Hers Health pays -- of its earnings as a dividend. European Wax Center pays out 7.54% of its earnings as a dividend. European Wax Center's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios HIMS or EWCZ?

    Hims & Hers Health quarterly revenues are $586M, which are larger than European Wax Center quarterly revenues of $51.4M. Hims & Hers Health's net income of $49.5M is higher than European Wax Center's net income of $1.7M. Notably, Hims & Hers Health's price-to-earnings ratio is 80.41x while European Wax Center's PE ratio is 28.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Hims & Hers Health is 7.50x versus 1.21x for European Wax Center. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HIMS
    Hims & Hers Health
    7.50x 80.41x $586M $49.5M
    EWCZ
    European Wax Center
    1.21x 28.14x $51.4M $1.7M
  • Which has Higher Returns HIMS or GROV?

    Grove Collaborative Holdings has a net margin of 8.44% compared to Hims & Hers Health's net margin of -8.15%. Hims & Hers Health's return on equity of 37.84% beat Grove Collaborative Holdings's return on equity of -164.34%.

    Company Gross Margin Earnings Per Share Invested Capital
    HIMS
    Hims & Hers Health
    73.5% $0.20 $549.3M
    GROV
    Grove Collaborative Holdings
    52.96% -$0.10 $20.6M
  • What do Analysts Say About HIMS or GROV?

    Hims & Hers Health has a consensus price target of $49.80, signalling downside risk potential of -10.25%. On the other hand Grove Collaborative Holdings has an analysts' consensus of $2.10 which suggests that it could grow by 82.61%. Given that Grove Collaborative Holdings has higher upside potential than Hims & Hers Health, analysts believe Grove Collaborative Holdings is more attractive than Hims & Hers Health.

    Company Buy Ratings Hold Ratings Sell Ratings
    HIMS
    Hims & Hers Health
    4 6 1
    GROV
    Grove Collaborative Holdings
    1 1 0
  • Is HIMS or GROV More Risky?

    Hims & Hers Health has a beta of 2.094, which suggesting that the stock is 109.43% more volatile than S&P 500. In comparison Grove Collaborative Holdings has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock HIMS or GROV?

    Hims & Hers Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Grove Collaborative Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Hims & Hers Health pays -- of its earnings as a dividend. Grove Collaborative Holdings pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios HIMS or GROV?

    Hims & Hers Health quarterly revenues are $586M, which are larger than Grove Collaborative Holdings quarterly revenues of $43.5M. Hims & Hers Health's net income of $49.5M is higher than Grove Collaborative Holdings's net income of -$3.5M. Notably, Hims & Hers Health's price-to-earnings ratio is 80.41x while Grove Collaborative Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Hims & Hers Health is 7.50x versus 0.22x for Grove Collaborative Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HIMS
    Hims & Hers Health
    7.50x 80.41x $586M $49.5M
    GROV
    Grove Collaborative Holdings
    0.22x -- $43.5M -$3.5M
  • Which has Higher Returns HIMS or KVUE?

    Kenvue has a net margin of 8.44% compared to Hims & Hers Health's net margin of 8.61%. Hims & Hers Health's return on equity of 37.84% beat Kenvue's return on equity of 10.32%.

    Company Gross Margin Earnings Per Share Invested Capital
    HIMS
    Hims & Hers Health
    73.5% $0.20 $549.3M
    KVUE
    Kenvue
    57.95% $0.17 $18.7B
  • What do Analysts Say About HIMS or KVUE?

    Hims & Hers Health has a consensus price target of $49.80, signalling downside risk potential of -10.25%. On the other hand Kenvue has an analysts' consensus of $24.54 which suggests that it could grow by 14.39%. Given that Kenvue has higher upside potential than Hims & Hers Health, analysts believe Kenvue is more attractive than Hims & Hers Health.

    Company Buy Ratings Hold Ratings Sell Ratings
    HIMS
    Hims & Hers Health
    4 6 1
    KVUE
    Kenvue
    2 13 0
  • Is HIMS or KVUE More Risky?

    Hims & Hers Health has a beta of 2.094, which suggesting that the stock is 109.43% more volatile than S&P 500. In comparison Kenvue has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock HIMS or KVUE?

    Hims & Hers Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Kenvue offers a yield of 3.82% to investors and pays a quarterly dividend of $0.21 per share. Hims & Hers Health pays -- of its earnings as a dividend. Kenvue pays out 150.68% of its earnings as a dividend.

  • Which has Better Financial Ratios HIMS or KVUE?

    Hims & Hers Health quarterly revenues are $586M, which are smaller than Kenvue quarterly revenues of $3.7B. Hims & Hers Health's net income of $49.5M is lower than Kenvue's net income of $322M. Notably, Hims & Hers Health's price-to-earnings ratio is 80.41x while Kenvue's PE ratio is 39.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Hims & Hers Health is 7.50x versus 2.70x for Kenvue. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HIMS
    Hims & Hers Health
    7.50x 80.41x $586M $49.5M
    KVUE
    Kenvue
    2.70x 39.00x $3.7B $322M
  • Which has Higher Returns HIMS or SKIN?

    The Beauty Health has a net margin of 8.44% compared to Hims & Hers Health's net margin of -14.51%. Hims & Hers Health's return on equity of 37.84% beat The Beauty Health's return on equity of -66.39%.

    Company Gross Margin Earnings Per Share Invested Capital
    HIMS
    Hims & Hers Health
    73.5% $0.20 $549.3M
    SKIN
    The Beauty Health
    69.82% -$0.08 $599M
  • What do Analysts Say About HIMS or SKIN?

    Hims & Hers Health has a consensus price target of $49.80, signalling downside risk potential of -10.25%. On the other hand The Beauty Health has an analysts' consensus of $1.76 which suggests that it could grow by 15.03%. Given that The Beauty Health has higher upside potential than Hims & Hers Health, analysts believe The Beauty Health is more attractive than Hims & Hers Health.

    Company Buy Ratings Hold Ratings Sell Ratings
    HIMS
    Hims & Hers Health
    4 6 1
    SKIN
    The Beauty Health
    0 7 0
  • Is HIMS or SKIN More Risky?

    Hims & Hers Health has a beta of 2.094, which suggesting that the stock is 109.43% more volatile than S&P 500. In comparison The Beauty Health has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock HIMS or SKIN?

    Hims & Hers Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Beauty Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Hims & Hers Health pays -- of its earnings as a dividend. The Beauty Health pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios HIMS or SKIN?

    Hims & Hers Health quarterly revenues are $586M, which are larger than The Beauty Health quarterly revenues of $69.6M. Hims & Hers Health's net income of $49.5M is higher than The Beauty Health's net income of -$10.1M. Notably, Hims & Hers Health's price-to-earnings ratio is 80.41x while The Beauty Health's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Hims & Hers Health is 7.50x versus 0.63x for The Beauty Health. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HIMS
    Hims & Hers Health
    7.50x 80.41x $586M $49.5M
    SKIN
    The Beauty Health
    0.63x -- $69.6M -$10.1M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Will Roku Stock Go?
How High Will Roku Stock Go?

Streaming software and hardware maker Roku (NASDAQ:ROKU) has seen its…

Where Will The Trade Desk’s Stock Be in 5 Years?
Where Will The Trade Desk’s Stock Be in 5 Years?

If you stitched together every advertisement The Trade Desk (NASDAQ:…

Is MSTR Stock Fundamentally Misunderstood?
Is MSTR Stock Fundamentally Misunderstood?

Software firm turned Bitcoin treasury Strategy (NASDAQ:MSTR) has made waves…

Stock Ideas

Buy
65
Is MSFT Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 40x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 48x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Alerts

Sell
11
VEON alert for Jun 14

VEON [VEON] is down 18.57% over the past day.

Buy
74
DAVE alert for Jun 14

Dave [DAVE] is down 12.68% over the past day.

Buy
54
DAR alert for Jun 14

Darling Ingredients [DAR] is up 9.12% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock